The impetus for Ego's automation program did not come from a crisis. It came from listening. Staff at Ego wanted to see continuous innovation applied to their processes and services, simpler workflows, effective collaboration, and a culture where process improvement was not an exception but an expectation.

At the same time, Ego's laboratory leadership had committed to a threefold strategic vision: to be Cleaner — maximizing process efficiency and cost-effectiveness; Greener — championing sustainability and green chemistry in line with the Twelve Principles of Green Chemistry; and Future Focused — driving continuous innovation through discovery and communication.

Translating that vision into practice required a systematic approach. The analytical development team mapped existing workflows, pinpointed bottlenecks, identified the most manual-heavy tasks, and prioritized multi-step procedures where automation could deliver the greatest gain. Two areas stood out immediately: UV/Vis spectrophotometric assays and titration for pharmaceutical ingredients such as glycerin. 

The UV/Vis automation program has been developed and validated through a unique model: undergraduate and master's students from Monash University, placed at Ego in the capable hands within the Analytical Development team, as part of a student internship program. The students carry out the development and optimization work under supervision, gaining real-world pharmaceutical analytical experience, while Ego benefits from structured method development resource. The work has been formally published in peer-reviewed application notes co-authored by Ego, ePrep, and METTLER TOLEDO — a testament to the scientific rigor applied throughout.

The program’s broader impact was recognized in late 2025 when the Royal Australian Chemical Institute (RACI) honored Helen Evans-Lemmo, the program coordinator, with its Victorian Branch Industry Mentor of the Year Award — acknowledging both the quality of the science and the social value of providing meaningful industry placements to the next generation of analytical chemists.

In a pharmaceutical QC environment, regulatory compliance is not optional — it is the fundamental requirement against which every method and every instrument must be assessed. For Ego, the decision to automate could not be made on efficiency and sustainability grounds alone. Every automated workflow had to demonstrate equivalence to the validated manual method, meet pharmacopeial requirements, and satisfy the data integrity standards demanded by 21 CFR Part 11 (for electronic records and signatures in regulated environments).

The combined ePrep ONE and METTLER TOLEDO LabX solution was designed with exactly these requirements in mind. The ePrep ONE operates on CFR Part 11-validated software with configurable user access controls and a comprehensive audit trail. The LabX platform consolidates all METTLER TOLEDO instruments — analytical balance, titrator, and UV/Vis spectrophotometer — into a single interface, providing complete digital traceability from the first measurement to the final result. Every sample ID, every mass recorded by the balance, every reagent addition by the ePrep ONE, and every titration endpoint determined by the T5 titrator is captured in a single, auditable data record.

The technical transfer adopted for each new automated method — progressing through information and risk identification, application methodology, determination of transfer approach, validation or verification, and data evaluation and reporting — reflects the structured, scientifically rigorous approach required in a regulated pharmaceutical environment. All validated automated methods have been published in peer-reviewed application notes co-authored by Ego, ePrep, and METTLER TOLEDO, providing full methodological transparency and supporting the regulatory submissions of Ego's partners and customers worldwide.

Ego's automation program is not a project with an end date — it is an ongoing commitment to continuous improvement that is now deeply embedded in laboratory culture. With a growing portfolio of validated automated methods, a proven collaboration framework with both METTLER TOLEDO and ePrep, and a student placement program that provides a continuous pipeline of development resource, the laboratory is well-positioned to extend automation to further analytical workflows in the years ahead.

From Ego's perspective, the ethos of ePrep and METTLER TOLEDO aligns naturally with its own: a shared commitment to precision, innovation, sustainability, and the empowerment of laboratory professionals. As observed in discussion with the METTLER TOLEDO team: "We believe that ePrep’s ethos aligns beautifully with Mettler's. Together, with or without further integration with ABB robotics, you could design something truly remarkable."

With management at Ego supportive of further collaborative development projects, the partnership is set to generate further innovation in pharmaceutical laboratory automation. The question is no longer whether to challenge existing processes. The question is what to improve next.